Patients undergoing high dose chemotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Bone Marrow Tumor Cells, Cultured Liver Hepatic Artery

Organisms4

Mice, Nude Rats, Sprague-Dawley Mice, Inbred BALB C Rats, Wistar

Diseases74

Lymphoma, Non-Hodgkin Breast Neoplasms Lung Neoplasms Neoplasms Neoplasm Recurrence, Local Vomiting Carcinoma, Non-Small-Cell Lung Neutropenia Neoplasm Metastasis Nausea Ovarian Neoplasms Adenocarcinoma Testicular Neoplasms Hodgkin Disease Colorectal Neoplasms Brain Neoplasms Leukopenia Recurrence Bone Neoplasms Neoplasms, Germ Cell and Embryonal Liver Neoplasms Osteosarcoma Peritoneal Neoplasms Carcinoma, Squamous Cell Lymphatic Metastasis Carcinoma Thrombocytopenia Precursor Cell Lymphoblastic Leukemia-Lymphoma Stomach Neoplasms Disease Progression Lymphoma Germinoma Leukemia, Myeloid, Acute Sarcoma Head and Neck Neoplasms Radiation Injuries Stomatitis Colonic Neoplasms Pancreatic Neoplasms Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Hematologic Diseases Multiple Myeloma Seminoma Mediastinal Neoplasms Disease Models, Animal Leukemia, Myeloid Neoplasms, Second Primary Central Nervous System Neoplasms Acute Disease Rectal Neoplasms Fever Leukemia Esophageal Neoplasms Drug-Related Side Effects and Adverse Reactions Urinary Bladder Neoplasms Nasopharyngeal Neoplasms Anemia Mucositis Neoplasms, Glandular and Epithelial Mesothelioma Soft Tissue Neoplasms Dysgerminoma Glioma Medulloblastoma Fatigue Melanoma Neoplasms, Experimental Lymphoma, B-Cell Pleural Neoplasms Glioblastoma Vomiting, Anticipatory Body Weight

Chemicals and Drugs66

Cyclophosphamide Antineoplastic Agents Cisplatin Doxorubicin Etoposide Methotrexate Carboplatin Paclitaxel Vinblastine Taxoids Ifosfamide Antimetabolites, Antineoplastic Bleomycin Deoxycytidine Organoplatinum Compounds Antineoplastic Agents, Alkylating Cytarabine Anthracyclines Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Melphalan Granulocyte Colony-Stimulating Factor Carmustine Dacarbazine Camptothecin Lomustine Antiemetics Platinum Compounds Thiotepa Antibodies, Monoclonal Mitomycin Mitoxantrone Antibodies, Monoclonal, Humanized Tumor Markers, Biological Prednisolone Daunorubicin Tegafur Bridged Compounds Vindesine Dexamethasone Recombinant Proteins Platinum Drug Combinations Antibodies, Monoclonal, Murine-Derived Oxonic Acid Mesna Receptor, erbB-2 Receptors, Estrogen P-Glycoprotein Mitomycins Nimustine Angiogenesis Inhibitors Tamoxifen Radiopharmaceuticals Granisetron Floxuridine Ondansetron Quinazolines Asparaginase Antineoplastic Agents, Hormonal Idarubicin Chlorambucil 6-Mercaptopurine Thioguanine Nitrosourea Compounds Biomarkers, Pharmacological

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Hematopoietic Stem Cell Transplantation Treatment Outcome Chemotherapy, Adjuvant Salvage Therapy Drug Administration Schedule Neoadjuvant Therapy Disease-Free Survival Survival Analysis Neoplasm Staging Survival Rate Prognosis Induction Chemotherapy Follow-Up Studies Radiotherapy Dosage Administration, Oral Infusions, Intravenous Chemotherapy, Cancer, Regional Perfusion Prospective Studies Radiotherapy Clinical Trials as Topic Radiotherapy, Adjuvant Radiation Dosage Kaplan-Meier Estimate Infusions, Intra-Arterial Dose-Response Relationship, Radiation Dose Fractionation Double-Blind Method Palliative Care Randomized Controlled Trials as Topic Injections, Intravenous Drug Therapy Lethal Dose 50 Drug Evaluation Feasibility Studies Bone Marrow Transplantation Radiometry Chemoradiotherapy Random Allocation Hyperthermia, Induced Tomography, X-Ray Computed Multivariate Analysis Cranial Irradiation Maintenance Chemotherapy Immunohistochemistry Infusions, Parenteral Actuarial Analysis Proportional Hazards Models Clinical Trials, Phase III as Topic Area Under Curve Risk Factors Fatal Outcome Treatment Failure Injections, Subcutaneous Pilot Projects Predictive Value of Tests Clinical Trials, Phase II as Topic Disease Models, Animal Injections, Intraperitoneal Analysis of Variance Leukocyte Count Drug Screening Assays, Antitumor Mastectomy Brachytherapy Hematopoietic Stem Cell Mobilization Xenograft Model Antitumor Assays Radiotherapy, Intensity-Modulated Immunotherapy Consolidation Chemotherapy Risk Assessment Cohort Studies Positron-Emission Tomography Neoplasm Transplantation Drug Delivery Systems Antineoplastic Protocols Radiotherapy Planning, Computer-Assisted Tumor Burden Radiotherapy, High-Energy Blood Cell Count Administration, Inhalation Neoplasms, Experimental Whole-Body Irradiation Stem Cell Transplantation Body Weight Drug Therapy, Combination Preoperative Care

Phenomena and Processes19

Dose-Response Relationship, Drug Time Factors Drug Resistance, Neoplasm Radiation Dosage Dose-Response Relationship, Radiation Lethal Dose 50 Apoptosis Drug Synergism Area Under Curve Cell Survival Drug Interactions Leukocyte Count Gene Expression Regulation, Neoplastic Drug Resistance Drug Resistance, Multiple Half-Life Cell Proliferation Blood Cell Count Body Weight

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Health Care33

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Clinical Trials as Topic Radiation Dosage Kaplan-Meier Estimate Dose-Response Relationship, Radiation Double-Blind Method Palliative Care Randomized Controlled Trials as Topic Feasibility Studies Random Allocation Radiation Injuries Multivariate Analysis Actuarial Analysis Proportional Hazards Models Clinical Trials, Phase III as Topic Area Under Curve Risk Factors Fatal Outcome Treatment Failure Pilot Projects Predictive Value of Tests Age Factors Clinical Trials, Phase II as Topic Analysis of Variance Risk Assessment Cohort Studies Antineoplastic Protocols Preoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Cyclophosphamide Hematopoietic Stem Cell Transplantation Antineoplastic Agents Treatment Outcome Chemotherapy, Adjuvant Lymphoma, Non-Hodgkin Salvage Therapy Dose-Response Relationship, Drug Cisplatin Doxorubicin Drug Administration Schedule Neoadjuvant Therapy Disease-Free Survival Etoposide Breast Neoplasms Survival Analysis Neoplasm Staging Lung Neoplasms Survival Rate Prognosis Methotrexate Carboplatin Paclitaxel Time Factors Neoplasms Vinblastine Neoplasm Recurrence, Local Induction Chemotherapy Taxoids Ifosfamide Drug Resistance, Neoplasm Antimetabolites, Antineoplastic Bleomycin Deoxycytidine Organoplatinum Compounds Follow-Up Studies Radiotherapy Dosage Antineoplastic Agents, Alkylating Cytarabine Administration, Oral Infusions, Intravenous Vomiting Anthracyclines Carcinoma, Non-Small-Cell Lung Neutropenia Neoplasm Metastasis Nausea Chemotherapy, Cancer, Regional Perfusion Ovarian Neoplasms Antineoplastic Agents, Phytogenic Adenocarcinoma Prospective Studies Radiotherapy Clinical Trials as Topic Testicular Neoplasms Hodgkin Disease Antibiotics, Antineoplastic Radiotherapy, Adjuvant Colorectal Neoplasms Melphalan Granulocyte Colony-Stimulating Factor Carmustine Dacarbazine Brain Neoplasms Leukopenia Camptothecin Radiation Dosage Recurrence Kaplan-Meier Estimate Infusions, Intra-Arterial Bone Neoplasms Lomustine Neoplasms, Germ Cell and Embryonal Cell Line, Tumor Dose-Response Relationship, Radiation Liver Neoplasms Osteosarcoma Dose Fractionation Antiemetics Double-Blind Method Platinum Compounds Thiotepa Antibodies, Monoclonal Mitomycin Mitoxantrone Antibodies, Monoclonal, Humanized Palliative Care Randomized Controlled Trials as Topic Injections, Intravenous Tumor Markers, Biological Peritoneal Neoplasms Drug Therapy Carcinoma, Squamous Cell Lymphatic Metastasis Prednisolone Carcinoma

No FAQ available that match "patients undergoing high dose chemotherapy"